![alexandros makriyannis alexandros makriyannis](https://news.northeastern.edu/wp-content/uploads/2012/04/makriyannis1.jpg)
Out of the growing number of players in the industry, recent results from Soligenix’s clinical trials seem to have caught the attention of many. SNGX advance research and development into CTCL with several clinical trials already underway. The need to find effective treatment regimens has seen players like Bausch Health Cos.
#Alexandros makriyannis skin#
In CTCL, the T cells develop abnormalities that make them attack the skin causing scaly patches or bumps called lesions or tumors. This is worrying because these white blood cells are part of the immune system that normally fight infection in the body. Unfortunately, these types of cancers - like cutaneous T-cell lymphoma (CTCL) - can be more unique and orphaned.ĬTCL is a rare type of cancer that begins in white blood cells called T cells (T lymphocytes). There are other types of cancer that are also equally if not more important to patients than the most popular ones. While there are more than 100 types of cancer, some - like breast, lung and prostate - are more common than others and therefore receive a lot of attention.
![alexandros makriyannis alexandros makriyannis](https://i1.rgstatic.net/ii/profile.image/350804599951367-1460649742543_Q512/Joshua-Hartsel.jpg)
Clinical trials are also giving hope to patients. Others who aren’t so lucky may have a combination of treatments, such as surgery, radiotherapy and drug treatments. Regular self-exams or medical screening for well-known cancers like skin, breast, mouth, testicles, prostate and rectum may lead to detection and treatment before the symptoms become serious.Įven though cancer is never good news, some people will have only one treatment. Thanks to advanced research and therapies, the earlier the cancer is diagnosed and treated, the better the chance of it being cured. Patients always have hope if their cancers are detected early.